Fanapt and Clonidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fanapt (iloperidone) and Clonidine (clonidine). Common drug interactions include tardive dyskinesia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Fanapt and Clonidine. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Fanapt?

Fanapt has active ingredients of iloperidone. It is often used in schizophrenia. eHealthMe is studying from 1,443 Fanapt users. Check the latest studies of Fanapt.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

16 people who take Fanapt and Clonidine together, and have interactions are studied.

Fanapt and Clonidine drug interactions.

What are the common drug interactions of Fanapt and Clonidine, by gender? *:

female:

  1. Tardive dyskinesia (a disorder that involves involuntary movements)
  2. Abnormal behaviour
  3. Blood prolactin increased
  4. Delusional perception (delusional perception describes, confusingly, a true perception, to which a patient attributes a false meaning)
  5. Diarrhoea
  6. Drug ineffective
  7. Gastric disorder (disease of stomach)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Heart rate increased
  10. Injury

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Death
  5. Priapism (prolonged and painful erection that can last from several hours up to a few days)
  6. Diarrhoea
  7. Rash pruritic (redness with itching)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Fanapt and Clonidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  2. Tardive dyskinesia (a disorder that involves involuntary movements)
  3. Diarrhoea
  4. Rash pruritic (redness with itching)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Tremor (trembling or shaking movements in one or more parts of your body)

20-29:

  1. Diarrhoea
  2. Drug ineffective
  3. Gastric disorder (disease of stomach)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Heart rate increased
  6. Loss of consciousness
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Death

30-39:

  1. Abnormal behaviour
  2. Chronic kidney disease
  3. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  4. Renal failure (kidney dysfunction)
  5. Renal injury (kidney injury)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)

50-59:

n/a

60+:

  1. Priapism (prolonged and painful erection that can last from several hours up to a few days)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
  2. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 18.75%
  3. Depression: 2 people, 12.50%
  4. Affective Disorder (mental disorder): 2 people, 12.50%
  5. Bipolar Disorder (mood disorder): 2 people, 12.50%
  6. Stress And Anxiety: 2 people, 12.50%
  7. Pain: 1 person, 6.25%
  8. Cough: 1 person, 6.25%
  9. Sleep Disorder: 1 person, 6.25%
  10. Sinusitis (inflammation of sinus): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Fanapt and Clonidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fanapt and Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fanapt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fanapt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clonidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on iloperidone and clonidine (the active ingredients of Fanapt and Clonidine, respectively), and Fanapt and Clonidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: